fda.gov· FDA·· 4 hours agoScore60
FDA Launches New Program to Advance Neuroscience Medical Product Development
In brief
The FDA has launched the Neuroscience Advancement and Innovation Nexus (NAIN) to coordinate development of medical products for brain and nervous system conditions. Its first initiative, the Alzheimer's Prevention Accelerator, will focus on Alzheimer's disease prevention.
Source: fda.gov · fda.gov